SHEILA WERTZ: Open Payments
NPI 1447618566 · CENTENNIAL, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,369 in 58 payments from 17 companies in 2025. Trend: 2023 $303 · 2024 $1,077 · 2025 $1,369
Food & beverage: $1,369
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $456 |
| Novartis Pharmaceuticals Corporation | 7 | $151 |
| GlaxoSmithKline, LLC. | 8 | $143 |
| GENZYME CORPORATION | 4 | $92 |
| Pharming Healthcare, Inc. | 3 | $78 |
| PFIZER INC. | 3 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $65 |
| Amgen Inc. | 2 | $55 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $45 |
| Regeneron Healthcare Solutions, Inc. | 2 | $45 |
Products named: TEZSPIRE, FASENRA, DUPIXENT, NUCALA, RUCONEST, OCTAGAM IMMUNE GLOBULIN (HUMAN), CUVITRU, Xolair.
Industry payments across CO — which companies pay providers there.
